Citation Impact
Citing Papers
Ent3p and Ent5p Exhibit Cargo-specific Functions in Trafficking Proteins between the Trans -Golgi Network and the Endosomes in Yeast
2007 StandoutNobel
Identification and proteomic profiling of exosomes in human urine
2004 Standout
In vivo siRNA delivery with dendritic poly( l -lysine) for the treatment of hypercholesterolemia
2009 StandoutNobel
Post-transcriptional Regulation of Low Density Lipoprotein Receptor Protein by Proprotein Convertase Subtilisin/Kexin Type 9a in Mouse Liver
2004
PCSK9: a convertase that coordinates LDL catabolism
2008
Genetic determinants of hepatic steatosis in man
2011
Cargo Selection in Vesicular Transport: The Making and Breaking of a Coat
2002
Biopsy and Noninvasive Methods to Assess Progression of Nonalcoholic Fatty Liver Disease
2016
Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function
2009 Standout
Therapeutic Potential of Moringa oleifera Leaves in Chronic Hyperglycemia and Dyslipidemia: A Review
2012 Standout
Multiple Cargo Binding Sites on the COPII Subunit Sec24p Ensure Capture of Diverse Membrane Proteins into Transport Vesicles
2003 StandoutNobel
Sorting Signals That Mediate Traffic of Chitin Synthase III between the TGN/Endosomes and to the Plasma Membrane in Yeast
2012 StandoutNobel
Thyroid Function and the Risk of Nonalcoholic Fatty Liver Disease: The Rotterdam Study
2016
Severe hypercholesterolaemia: therapeutic goals and eligibility criteria for LDL apheresis in Europe
2010
Modulation of lipoprotein receptor functions by intracellular adaptor proteins
2006
Regulated portals of entry into the cell
2003 StandoutNature
Contribution of Primary Care to Health Systems and Health
2005 Standout
Current complications and challenges in nonalcoholic steatohepatitis screening and diagnosis
2015
Proprotein convertase subtilisin/kexin type 9 (PCSK9): From structure–function relation to therapeutic inhibition
2011
Review and Metaanalysis of the Frequency of Familial Dilated Cardiomyopathy
2011
Monovalent, reduced-size quantum dots for imaging receptors on living cells
2008 StandoutNobel
How to improve R&D productivity: the pharmaceutical industry's grand challenge
2010 Standout
Predictable and precise template-free CRISPR editing of pathogenic variants
2018 Nature
Pollutants bioavailability and toxicological risk from microplastics to marine mussels
2015 Standout
Disabled-2 exhibits the properties of a cargo-selective endocytic clathrin adaptor
2002
Evidence‐Based Medicine, Heterogeneity of Treatment Effects, and the Trouble with Averages
2004
Macrophages take up triacylglycerol‐rich emulsions at a faster rate upon co‐incubation with native and modified LDL: An investigation on the role of natural chylomicrons in atherosclerosis
2001
Search-and-replace genome editing without double-strand breaks or donor DNA
2019 StandoutNature
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
2003
Genome editing with CRISPR–Cas nucleases, base editors, transposases and prime editors
2020 Standout
Prescribing Personalized Nutrition for Cardiovascular Health: Are We Ready?
2014 Standout
Molecular mechanism and physiological functions of clathrin-mediated endocytosis
2011 Standout
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5
2003 StandoutNature
The Modular Adaptor Protein Autosomal Recessive Hypercholesterolemia (ARH) Promotes Low Density Lipoprotein Receptor Clustering into Clathrin-coated Pits
2005
PCSK9 and LDL cholesterol: unravelling the target to design the bullet
2008
Mechanisms of Disease: genetic causes of familial hypercholesterolemia
2007
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins
2011 Standout
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
2006 Standout
The Modular Adaptor Protein ARH Is Required for Low Density Lipoprotein (LDL) Binding and Internalization but Not for LDL Receptor Clustering in Coated Pits
2004
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion
2013 StandoutNobel
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Eighth Special Issue
2019 Standout
The adaptor protein Dab2 sorts LDL receptors into coated pits independently of AP-2 and ARH
2006
UNC93B1 mediates differential trafficking of endosomal TLRs
2013 StandoutNobel
Bioactive compounds in seaweed: functional food applications and legislation
2011 Standout
Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey
2014
Signals for Sorting of Transmembrane Proteins to Endosomes and Lysosomes
2003 Standout
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
2015 Standout
Monogenic hypercholesterolemia: new insights in pathogenesis and treatment
2003
The Exomer Coat Complex Transports Fus1p to the Plasma Membrane via a Novel Plasma Membrane Sorting Signal in Yeast
2009 StandoutNobel
The Role ofVldlrin Intraretinal Angiogenesis in Mice
2011 StandoutNobel
Autosomal Recessive Hypercholesterolemia Caused by Mutations in a Putative LDL Receptor Adaptor Protein
2001 Science
Disruption of Autosomal Recessive Hypercholesterolemia Gene Shows Different Phenotype In Vitro and In Vivo
2004
V Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose
2013 Standout
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
Nonalcoholic Fatty Liver Disease
2015 Standout
Mechanisms of Endocytosis
2009 Standout
Works of Mafalda Bourbon being referenced
Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations
2008
Characterization of a novel cellular defect in patients with phenotypic homozygous familial hypercholesterolemia
1999
Familial hypercholesterolaemia in Portugal
2007
How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound
2013
Low-density lipoprotein receptor mutational analysis in diagnosis of familial hypercholesterolemia
2017
Portuguese study of familial dilated cardiomyopathy: the FATIMA study.
2008
Determinants of Variable Response to Statin Treatment in Patients With Refractory Familial Hypercholesterolemia
2001